Cargando…
A Novel Antimicrobial Endolysin, LysPA26, against Pseudomonas aeruginosa
The global increase in multidrug resistant (MDR) bacteria has led to phage therapy being refocused upon. A novel endolysin, LysPA26, containing a lysozyme-like domain, was screened against Pseudomonas aeruginosa in this study. It had activity against MDR P. aeruginosa without pretreatment with an ou...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326749/ https://www.ncbi.nlm.nih.gov/pubmed/28289407 http://dx.doi.org/10.3389/fmicb.2017.00293 |